Editas Medicine, Inc. , a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases.
Editas Medicine stock last closed at $7.42, down 0.27% from the previous day, and has increased 4.36% in one year. It has overperformed other stocks in the Biotechnology industry by 0.09 percentage points. Editas Medicine stock is currently +22.04% from its 52-week low of $6.08, and -37.7% from its 52-week high of $11.91.
There are currently 81.81M EDIT shares outstanding. The market value of EDIT is $607.06M. In the past 24 hours, 1.52M EDIT shares were traded.
How to Buy Editas Medicine Stock
Wondering how to invest in Editas Medicine stock? Here's how.
Figure out where to buy Editas Medicine stock: You need to pick an online brokerage, but don't worry - we've tested dozens of online stock brokerages and apps to help you decide where to buy Editas Medicine stock.
Sign up for your brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've identified.
Fund your brokerage account: Choose your method of payment and add your details.
Research Editas Medicine stock: The Editas Medicine ticker symbol is EDIT. Is Editas Medicine stock a good investment? Should you buy shares of EDIT? How do EDIT's underlying business fundamentals look? Do top analysts think Editas Medicine is a good buy? Why has EDIT's stock price moved recently? (Hint: Our stock market analysis website can help you decide if EDIT is a good stock to buy).
Execute your EDIT trade: Decide if you will purchase EDIT shares at the current market price or use a limit order to purchase EDIT shares at a given price.
Get notifications regarding your EDIT investment: Create a watchlist to keep tabs on your position in Editas Medicine shares.
Step 1: Figure out where to buy Editas Medicine stock
You will need a brokerage account to access the NASDAQ market and buy EDIT stock.
A brokerage account is an investment account that enables you to buy and sell a variety of financial instruments, such as stocks, bonds, mutual funds, and ETFs.
Our favorite brokerage: eToro
We believe that eToro is the best brokerage. eToro gives you:
Invest in stocks with 0% commissions: Invest without paying trading commissions.
Buy fractional shares: Even if you don't have the money to buy a full share, you can still purchase the stock.
Access to global markets: From Tech to Industrials, New York to Shanghai — you can fill your portfolio with stocks from the world's top exchanges.
Social investing: eToro boasts a community with more than 20 million users worldwide. Talk to, learn from, and copy the unique crypto portfolios of other investors.
Security: eToro is a regulated and licensed brokerage platform.
Buy other assets: Such as ETFs and cryptocurrencies.
Get $10 towards your stock purchase by signing up for an account with eToro now.
eToro securities trading is offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency is offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. https://www.wallstreetzen.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD.
Step 2: Sign up for your brokerage account
Now that you've picked the right brokerage, you need to fill out some personal details so you can invest in EDIT today.
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
Step 4: Research Editas Medicine stock
After you have chosen the best place to buy Editas Medicine stock, it's crucial to analyze their stock prior to buying, so you can wrap your head around the risk as well as the opportunity.
Editas Medicine Numbers
EDIT Price
$7.42
1w %
-5.24%
1y %
4.36%
5y %
-68.6%
P/E
-3.67x
P/B
1.74x
P/S
7.22x
PEG
N/A
Revenue
$78.12M
Earnings
-$153.22M
Fore. Rev. Growth
9.55%
Fore. Earn. Growth
N/A
Market Cap
$607.06M
Next Earnings
May 3, 2024
Next Dividend
N/A
Fundamentals of EDIT
WallStreetZen was designed to help everyday investors perform better fundamental analysis in less time.
Last year, EDIT revenue was $78.12M. In the past five year, EDIT's revenue has increased by 19.59% per year. This was slower than the Biotechnology industry average of 29.51%.
No, Editas Medicine doesn't provide an income stream by paying out dividends.
What others are saying about EDIT
One of the major reasons eToro is our top-rated brokerage is because of its social trading community.
Click below to find out what other community members have to say.
Step 5: Execute your EDIT trade
You have two primary order types:
Market order: A market order is an order to buy or sell a stock at the best available price. Market orders are usually the best for newer investors.
Limit order: A limit order enables you to buy or sell a security at a specific price (or better). If you want to be certain you're buying or selling at a specific price, place a limit order.
Hit the Open Trade button and eToro will place your order.
If you need more assistance buying stocks on eToro, click the helpful video below:
How much does it cost to buy one Editas Medicine share?
As of Mar 28, 2024, it costs $7.42 to buy one share of Editas Medicine stock.
Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $3, you can buy 0.404 shares of EDIT.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.